| |||||||
|
|
|
|
The cancer research program known as the Kansas City Clinical Oncology Program (KCCOP)
is a cooperative effort involving 12 Kansas
City area health care organizations,
as well as over 50
medical oncologists,
radiation oncologists,
surgeons
and
other specialists.
The KCCOP is one of 52 such programs established by the National Cancer
Institute (NCI) to provide patients with access to national research studies
while remaining in their own communities. The KCCOP affiliates with major research centers throughout the nation to bring the benefits of cutting edge cancer research to Kansas City through participation in studies with the Southwest Oncology Group, M.D. Anderson Cancer Center, the National Surgical Adjuvant Breast & Bowel Project, the Radiation Therapy Oncology Group, the Gynecologic Oncology Group, the Cancer & Leukemia Group B, and the University of Rochester Cancer Center. As one of the national trial centers located throughout the U.S., the KCCOP recruits patients to participate in investigational cancer studies designed to determine ways to prevent, detect, diagnose, and treat cancer. |
|
|